Jan Holst

51 – 60 of 65

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/3ce514f3-5fc6-4488-b3e1-b1790fc715ca?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
…
4
5
6
7
next »

2006
Mark The vasorelaxant effect of adrenomedullin, proadrenomedullin N-terminal 20 peptide and amylin in human skin
Hasbak, Philip ; Eskesen, Karen ; Lind, Henrik ; Holst, Jan ^LU and Edvinsson, Lars ^LU (2006) In Basic & Clinical Pharmacology & Toxicology 99(2). p.162-167
- Contribution to journal › Article
Mark Från primärvård till invasiv intervention. Den kärlsjuke patientens väg genom svensk sjukvård
Bergqvist, David ; Delle, Martin ; Eckerlund, Ingemar ; Marké, Lars Åke ; Säwe, Juliette ; Holst, Jan ^LU ; Mattiasson, Ingrid ^LU ; Jogestrand, Tomas ; Jörneskog, Gun and Klevsgård, Rosemarie , et al. (2006) In Läkartidningen 103(1-2). p.38-40
- Contribution to journal › Article
1998
Mark Local application of recombinant active-site inhibited human clotting factor VIIa reduces thrombus weight and improves patency in a rabbit venous thrombosis model
Holst, J. ^LU ; Kristensen, A. T. ; Kristensen, H. I. ; Ezban, M. and Hedner, U. ^LU (1998) In European Journal of Vascular and Endovascular Surgery 15(6). p.515-520
- Contribution to journal › Article
1997
Mark The effect of protamine sulphate on plasma tissue factor pathway inhibitor released by intravenous and subcutaneous unfractionated and low molecular weight heparin in man
Holst, Jan ^LU ; Lindblad, Bengt ^LU ; Bergqvist, David ; Hedner, Ulla ; Nordfang, Ole and Ostergaard, Per (1997) In Thrombosis Research 86(4). p.343-348
- Contribution to journal › Article
1996
Mark Experimental haemorrhagic effect of two-domain non-glycosylated tissue factor pathway inhibitor compared to low molecular weight heparin
Holst, Jan ^LU ; Lindblad, Bengt ^LU ; Matthíasson, Stefan E. ; Stjernquist, Ulf ; Ezban, Mirella ; Østergaard, Per B. and Hedner, Ulla ^LU (1996) In Thrombosis and Haemostasis 75(4). p.585-589
- Contribution to journal › Article
Mark Pharmacokinetics and delayed experimental anti-thrombotic effect of two domain non-glycosylated tissue factor pathway inhibitor
Holst, Jan ^LU ; Lindblad, Bengt ^LU ; Westerlund, Gertie ; Bregengaard, Claus ; Ezban, Mirella ; ØStergaard, Per B. ; Nordfang, Ole and Hedner, Ulla ^LU (1996) In Thrombosis Research 81(4). p.461-470
- Contribution to journal › Article
Mark Does glycosylation influence the experimental antithrombotic effect of a two-domain tissue factor pathway inhibitor?
Holst, Jan ^LU ; Lindblad, Beugt ^LU ; Nordfang, Oie ; Østergaard, Per B. and Hedner, Ulla ^LU (1996) In Pathophysiology of Haemostasis and Thrombosis 26(1). p.23-30
- Contribution to journal › Article
Mark Effect of low-molecular-weight heparin (Tinzaparin) and unfractionated heparin on platelet aggregation
Ravn, Hanne B. ; Bregengaard, Claus ; Vissinger, Henrik ; Østergaard, Per ; Holst, Jan ^LU ; Nielsen, Hans K. ; Kristensen, Steen D. and Husted, Steen E. (1996) In Clinical and Applied Thrombosis/Hemostasis 2(3). p.209-212
- Contribution to journal › Article
1994
Mark Effect of low molecular weight heparin, dextran and their combinations on experimental venous thrombosis in rabbits
Matthiasson, S E ; Lindblad, Bengt ^LU ; Mätzsch, Thomas ^LU ; Holst, Jan ^LU and Bergqvist, D (1994) In Thrombosis and Haemostasis 71(3). p.363-365
- Contribution to journal › Article
Mark Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin(TM)). An experimental investigation in healthy volunteers
Holst, J. ^LU ; Lindblad, B. ^LU ; Bergqvist, D. ; Garre, K. ; Nielsen, H. ; Hedner, U. ^LU and Ostergaard, P. B. (1994) In Blood Coagulation and Fibrinolysis 5(5). p.795-803
- Contribution to journal › Article

« previous
1
2
…
4
5
6
7
next »